SDEVNYSEFinance ServicesFiscal year ends December 31
Stablecoin Development Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$0.84−0.04 (-4.81%)
Close on Oct 19, 2026
- Market cap
- $26.03M
- P/E (TTM)
- –
- Dividend yield
- 477.10%
Stablecoin Development Corp revenue by segment
By business segment
| Revenue | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | Q1 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Skincare [Member] | – | – | – | – | – | – | – | – | – | $1.32M | $592.00K | $891.00K | – | – |
| Optical and Wound Care [Member] | – | – | – | – | $2.82M | $2.48M | $3.53M | $2.34M | $2.59M | $2.51M | $2.91M | $2.23M | – | – |
| Skin Care [Member] | – | – | – | – | $907.00K | $784.00K | $1.08M | $785.00K | $1.05M | $1.32M | $752.00K | $1.04M | – | – |
| Operating income | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | Q1 22 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Skincare [Member] | – | – | – | – | – | – | – | – | – | -$200.00K | -$844.00K | -$343.00K | – |
| Optical and Wound Care [Member] | – | – | – | – | -$556.00K | -$698.00K | -$1.06M | -$1.34M | -$2.04M | -$257.00K | -$1.31M | -$2.04M | – |
| Skin Care [Member] | – | – | – | – | -$2.84M | -$418.00K | -$293.00K | -$399.00K | -$7.39M | -$200.00K | -$844.00K | -$343.00K | – |
By product or service
| Revenue | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | Q1 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $2.31M | $2.42M | $2.39M | $2.62M | $2.13M | $2.47M | $3.52M | $2.33M | $3.63M | $3.82M | $3.66M | $3.27M | 23.6% | +8.6% |
| Total Product Revenue [Member] | $2.31M | $2.42M | $2.39M | $2.62M | $2.13M | $2.47M | $3.52M | $2.33M | $3.63M | $3.82M | $3.66M | $3.27M | 23.6% | +8.6% |
| Avenova Spray [Member] | $2.28M | $2.17M | $2.13M | $2.10M | $2.05M | $2.06M | $1.76M | $1.94M | $1.87M | $1.94M | $2.00M | $1.84M | 23.3% | +11.5% |
| Other Products [member] | $30.00K | $254.00K | $262.00K | $528.00K | $429.00K | $407.00K | $722.00K | $395.00K | $399.00K | $558.00K | $398.00K | $237.00K | 0.3% | -93.0% |
| NeutroPhase [Member] | $0 | $0 | $0 | – | $334.00K | $0 | $1.04M | $0 | $319.00K | $0 | $509.00K | $148.00K | 0.0% | -100.0% |
| Product and Service, Other [Member] | – | $17.00K | $13.00K | $7.00K | $11.00K | $10.00K | $11.00K | $7.00K | $12.00K | $10.00K | $2.00K | $6.00K | – | – |
| Avenova Direct [Member] | – | $1.90M | $1.70M | $1.80M | – | $1.60M | $1.30M | $1.60M | $1.40M | $1.60M | $1.30M | $1.80M | – | – |
| DERMAdoctor [Member] | – | – | – | – | $907.00K | $784.00K | $1.08M | $785.00K | $1.04M | $1.32M | $752.00K | $1.04M | – | – |
| Avenova Product [Member] | – | – | – | – | – | – | – | – | $1.40M | $1.60M | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Stablecoin Development's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.